{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:02:46Z","timestamp":1792587766975,"version":"4.5.0"},"reference-count":310,"publisher":"American Society for Microbiology","issue":"5","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[2026,5,19]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Mucosal vaccines hold many advantages over parenteral vaccines in the prevention of respiratory infections, which remain a major global health burden. Unlike parenteral vaccines, which primarily induce systemic immunity, mucosal vaccines stimulate robust local immune responses, including secretory IgA, tissue-resident memory T and B cells, and mucosal IgG. These responses collectively block viral entry, limit replication, and reduce transmission. Critically, they provide protection at the site of infection, offering rapid and durable immunity. This review highlights recent advances in mucosal vaccine platforms and delivery strategies for respiratory viruses, including emerging vaccine platforms, adjuvants, and heterologous prime-boost approaches, with a focus on findings from both animal models and human studies that define the key immune components and mechanisms of action in mucosal immunity. We further discuss evidence across major respiratory viruses and the translational and clinical implications for next-generation vaccine design. These insights underscore the role of mucosal vaccines in strengthening future pandemic preparedness.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1128\/jvi.00146-26","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T12:30:46Z","timestamp":1776256246000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":5,"title":["Combating respiratory diseases with mucosal vaccines"],"prefix":"10.1128","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-2715-6105","authenticated-orcid":false,"given":"Patrick Chun Hean","family":"Tang","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02hsggv49","id-type":"ROR","asserted-by":"publisher"}],"name":"Emerging Viruses, Inflammation and Therapeutics Group, Institute for Biomedicine and Glycomics, Griffith University","place":["Gold Coast, Australia"]},{"id":[{"id":"https:\/\/ror.org\/02sc3r913","id-type":"ROR","asserted-by":"publisher"}],"name":"Global Virus Network (GVN) Centre of Excellence in Arboviruses, Griffith University","place":["Gold Coast, Australia"]},{"id":[{"id":"https:\/\/ror.org\/02sc3r913","id-type":"ROR","asserted-by":"publisher"}],"name":"School of Pharmacy and Medical Sciences, Griffith University","place":["Gold Coast, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Ling","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0384j8v12","id-type":"ROR","asserted-by":"publisher"}],"name":"Viral Immunopathology Laboratory, Infection, Immunity and Inflammation Research Theme, Charles Perkins Centre, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney","place":["Sydney, Australia"]},{"id":[{"id":"https:\/\/ror.org\/0384j8v12","id-type":"ROR","asserted-by":"publisher"}],"name":"Sydney Institute for Infectious Diseases, The University of Sydney","place":["Sydney, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9880-3971","authenticated-orcid":false,"given":"Mabel","family":"Lee","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02hsggv49","id-type":"ROR","asserted-by":"publisher"}],"name":"Emerging Viruses, Inflammation and Therapeutics Group, Institute for Biomedicine and Glycomics, Griffith University","place":["Gold Coast, Australia"]},{"id":[{"id":"https:\/\/ror.org\/02sc3r913","id-type":"ROR","asserted-by":"publisher"}],"name":"Global Virus Network (GVN) Centre of Excellence in Arboviruses, Griffith University","place":["Gold Coast, Australia"]},{"id":[{"id":"https:\/\/ror.org\/02sc3r913","id-type":"ROR","asserted-by":"publisher"}],"name":"School of Pharmacy and Medical Sciences, Griffith University","place":["Gold Coast, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3877-9772","authenticated-orcid":false,"given":"Nicholas J. C.","family":"King","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02hsggv49","id-type":"ROR","asserted-by":"publisher"}],"name":"Emerging Viruses, Inflammation and Therapeutics Group, Institute for Biomedicine and Glycomics, Griffith University","place":["Gold Coast, Australia"]},{"id":[{"id":"https:\/\/ror.org\/0384j8v12","id-type":"ROR","asserted-by":"publisher"}],"name":"Viral Immunopathology Laboratory, Infection, Immunity and Inflammation Research Theme, Charles Perkins Centre, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney","place":["Sydney, Australia"]},{"id":[{"id":"https:\/\/ror.org\/0384j8v12","id-type":"ROR","asserted-by":"publisher"}],"name":"Sydney Institute for Infectious Diseases, The University of Sydney","place":["Sydney, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3141-8410","authenticated-orcid":true,"given":"Suresh","family":"Mahalingam","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02hsggv49","id-type":"ROR","asserted-by":"publisher"}],"name":"Emerging Viruses, Inflammation and Therapeutics Group, Institute for Biomedicine and Glycomics, Griffith University","place":["Gold Coast, Australia"]},{"id":[{"id":"https:\/\/ror.org\/02sc3r913","id-type":"ROR","asserted-by":"publisher"}],"name":"Global Virus Network (GVN) Centre of Excellence in Arboviruses, Griffith University","place":["Gold Coast, Australia"]},{"id":[{"id":"https:\/\/ror.org\/02sc3r913","id-type":"ROR","asserted-by":"publisher"}],"name":"School of Pharmacy and Medical Sciences, Griffith University","place":["Gold Coast, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","unstructured":"WHO. 2024. The top 10 causes of death. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/the-top-10-causes-of-death"},{"key":"e_1_3_2_3_2","unstructured":"International Respiratory Coalition. 2025. LRTIs in numbers. Available from: https:\/\/international-respiratory-coalition.org\/diseases\/covid-19"},{"key":"e_1_3_2_4_2","unstructured":"International Respiratory Coalition. 2025. Lung facts-Europe. Available from: https:\/\/international-respiratory-coalition.org\/countries\/europe"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2017.1264829"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28153"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1353\/bhm.2002.0022"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.4103\/0256-4947.59365"},{"key":"e_1_3_2_9_2","unstructured":"Australian Government. 2024. Health-H1N1 pandemic. Available from: https:\/\/knowledge.aidr.org.au\/resources\/health-h1n1-pandemic\/#:~:text=The%20Centers%20for%20Disease%20Control under%2065%20years%20of%20age"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1176225"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00478-0"},{"key":"e_1_3_2_12_2","unstructured":"WHO. 2025. Respiratory syncytial virus (RSV). Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/respiratory-syncytial-virus-(rsv)"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.46010"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad559"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.3390\/v16040507"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiae064"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1011.040729"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-018-0118-9"},{"key":"e_1_3_2_19_2","unstructured":"Care AGDoHaA. 2023. Storing handling and administering vaccines. Available from: https:\/\/www.health.gov.au\/topics\/immunisation\/immunisation-information-for-health-professionals\/storing-handling-and-administering-vaccines"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065944"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010821"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.25998.1"},{"key":"e_1_3_2_23_2","unstructured":"Gritstonebio. 2021. Gritstone and CEPI announce agreement to advance second-generation COVID-19 Vaccine Program (CORAL) against SARS-CoV-2 variants of concern"},{"key":"e_1_3_2_24_2","unstructured":"CEPI. 2024. Global consortium plans coordinated human challenge studies in hunt for transmission-blocking coronavirus vaccines. Available from: https:\/\/cepi.net\/global-consortium-plans-coordinated-human-challenge-studies-hunt-transmission-blocking-coronavirus"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-10-321"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2021.03.014"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2005.07.001"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0308001101"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2312-y"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.76.11.5654-5666.2002"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-003-0898-8"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.11.5416-5420.2001"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2021.108850"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200535493"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00611"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.772240"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00312"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aam6970"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2013.67"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20142284"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20160938"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.110169"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.9.5861"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1158"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-01091-0"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13143"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2022.03.003"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201344359"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006140"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00291-10"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1177\/03009858221095270"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adm8836"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-023-01661-4"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-021-00258-1"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-03148-w"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102833"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.86764"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37425-9"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010395"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20232192"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-022-00964-2"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20112667"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2006-0234OC"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0397-8"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.11.6861"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0408-z"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.02.005"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113299"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1102038"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20052359"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-018-0097-1"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.045021-0"},{"key":"e_1_3_2_73_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.80.10.5032-5040.2006"},{"key":"e_1_3_2_74_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.175.9.5904"},{"key":"e_1_3_2_75_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1400760111"},{"key":"e_1_3_2_76_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22179228"},{"key":"e_1_3_2_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.07.026"},{"key":"e_1_3_2_78_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-021-00681-2"},{"key":"e_1_3_2_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2020.05.019"},{"key":"e_1_3_2_80_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa356"},{"key":"e_1_3_2_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2025.04.005"},{"key":"e_1_3_2_82_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0568-x"},{"key":"e_1_3_2_83_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2024.08.018"},{"key":"e_1_3_2_84_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.09.042"},{"key":"e_1_3_2_85_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10486-5"},{"key":"e_1_3_2_86_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-016-0571-3"},{"key":"e_1_3_2_87_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.02.023"},{"key":"e_1_3_2_88_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-022-00815-z"},{"key":"e_1_3_2_89_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0260-6"},{"key":"e_1_3_2_90_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.188.2.223"},{"key":"e_1_3_2_91_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7833"},{"key":"e_1_3_2_92_2","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.3701261"},{"key":"e_1_3_2_93_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23018-x"},{"key":"e_1_3_2_94_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30088-y"},{"key":"e_1_3_2_95_2","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abf6692"},{"key":"e_1_3_2_96_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad2035"},{"key":"e_1_3_2_97_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature24993"},{"key":"e_1_3_2_98_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature02284"},{"key":"e_1_3_2_99_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2744"},{"key":"e_1_3_2_100_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115725"},{"key":"e_1_3_2_101_2","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.85832"},{"key":"e_1_3_2_102_2","doi-asserted-by":"publisher","DOI":"10.4049\/immunohorizons.2000067"},{"key":"e_1_3_2_103_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1102243"},{"key":"e_1_3_2_104_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1402975"},{"key":"e_1_3_2_105_2","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abl9105"},{"key":"e_1_3_2_106_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00665-3"},{"key":"e_1_3_2_107_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37559-w"},{"key":"e_1_3_2_108_2","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.add4853"},{"key":"e_1_3_2_109_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42433-w"},{"key":"e_1_3_2_110_2","doi-asserted-by":"publisher","DOI":"10.4049\/immunohorizons.2100074"},{"key":"e_1_3_2_111_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.943331"},{"key":"e_1_3_2_112_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-023-00853-1"},{"key":"e_1_3_2_113_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj2710285"},{"key":"e_1_3_2_114_2","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2011.39"},{"key":"e_1_3_2_115_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1117749"},{"key":"e_1_3_2_116_2","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abj5129"},{"key":"e_1_3_2_117_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-06880-3"},{"key":"e_1_3_2_118_2","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abc8413"},{"key":"e_1_3_2_119_2","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abe5511"},{"key":"e_1_3_2_120_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI138759"},{"key":"e_1_3_2_121_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.138.2.435"},{"key":"e_1_3_2_122_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.611337"},{"key":"e_1_3_2_123_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07748-8"},{"key":"e_1_3_2_124_2","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2019.0141"},{"key":"e_1_3_2_125_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abh0755"},{"key":"e_1_3_2_126_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-021-00315-6"},{"key":"e_1_3_2_127_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26178-y"},{"key":"e_1_3_2_128_2","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines3020373"},{"key":"e_1_3_2_129_2","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2017.1377376"},{"key":"e_1_3_2_130_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51535-y"},{"key":"e_1_3_2_131_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104585"},{"key":"e_1_3_2_132_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1078904"},{"key":"e_1_3_2_133_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1231697"},{"key":"e_1_3_2_134_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(23)00102-7"},{"key":"e_1_3_2_135_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacig.2023.100129"},{"key":"e_1_3_2_136_2","doi-asserted-by":"publisher","DOI":"10.4161\/hv.6.9.11561"},{"key":"e_1_3_2_137_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01557-7"},{"key":"e_1_3_2_138_2","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10050819"},{"key":"e_1_3_2_139_2","doi-asserted-by":"publisher","DOI":"10.1111\/apm.12351"},{"key":"e_1_3_2_140_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2018.10.041"},{"key":"e_1_3_2_141_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2020.02.011"},{"key":"e_1_3_2_142_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2007.04.021"},{"key":"e_1_3_2_143_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2011.01.004"},{"key":"e_1_3_2_144_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2008.11.002"},{"key":"e_1_3_2_145_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2019.04.001"},{"key":"e_1_3_2_146_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2021.101139"},{"key":"e_1_3_2_147_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-017-0043-3"},{"key":"e_1_3_2_148_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046094"},{"key":"e_1_3_2_149_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41578-021-00358-0"},{"key":"e_1_3_2_150_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.9.6159"},{"key":"e_1_3_2_151_2","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2013.0013"},{"key":"e_1_3_2_152_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.02.019"},{"key":"e_1_3_2_153_2","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/686549"},{"key":"e_1_3_2_154_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-025-01123-y"},{"key":"e_1_3_2_155_2","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202000771"},{"key":"e_1_3_2_156_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2025.127183"},{"key":"e_1_3_2_157_2","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10040593"},{"key":"e_1_3_2_158_2","doi-asserted-by":"publisher","DOI":"10.1111\/imr.13118"},{"key":"e_1_3_2_159_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.3c11756"},{"key":"e_1_3_2_160_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.131289"},{"key":"e_1_3_2_161_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.1c01243"},{"key":"e_1_3_2_162_2","unstructured":"Biolabs A. 2022. ACM Biolabs\u2019 intranasal COVID vaccine presents excellent preclinical results with broad protection against variants of concerns including omicron"},{"key":"e_1_3_2_163_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.11.032"},{"key":"e_1_3_2_164_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.09.007"},{"key":"e_1_3_2_165_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50133-2"},{"key":"e_1_3_2_166_2","doi-asserted-by":"publisher","DOI":"10.2165\/11206860-000000000-00000"},{"key":"e_1_3_2_167_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201142346"},{"key":"e_1_3_2_168_2","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10122087"},{"key":"e_1_3_2_169_2","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12091001"},{"key":"e_1_3_2_170_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.2c06350"},{"key":"e_1_3_2_171_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2200297"},{"key":"e_1_3_2_172_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2023.102388"},{"key":"e_1_3_2_173_2","doi-asserted-by":"publisher","DOI":"10.1038\/natrevmats.2017.56"},{"key":"e_1_3_2_174_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2023.05.011"},{"key":"e_1_3_2_175_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2016.02.043"},{"key":"e_1_3_2_176_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.3c12604"},{"key":"e_1_3_2_177_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169501"},{"key":"e_1_3_2_178_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.10.058"},{"key":"e_1_3_2_179_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.07.058"},{"key":"e_1_3_2_180_2","doi-asserted-by":"publisher","DOI":"10.4161\/hv.27383"},{"key":"e_1_3_2_181_2","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevImmunol.v30.i2.60"},{"key":"e_1_3_2_182_2","unstructured":"CDC. 2022. Live attenuated influenza vaccine [LAIV] (the nasal spray flu vaccine). Available from: https:\/\/www.cdc.gov\/flu\/prevent\/nasalspray.htm. Retrieved 25 Sep 2024."},{"key":"e_1_3_2_183_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06951-3"},{"key":"e_1_3_2_184_2","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12060643"},{"key":"e_1_3_2_185_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20210583"},{"key":"e_1_3_2_186_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2023.01.003"},{"key":"e_1_3_2_187_2","doi-asserted-by":"publisher","DOI":"10.1016\/b978-0-12-811924-2.00002-x:21-54"},{"key":"e_1_3_2_188_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf6413"},{"key":"e_1_3_2_189_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.03.081"},{"key":"e_1_3_2_190_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00717-8"},{"key":"e_1_3_2_191_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45348-2"},{"key":"e_1_3_2_192_2","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adh1655"},{"key":"e_1_3_2_193_2","doi-asserted-by":"publisher","DOI":"10.1111\/irv.70093"},{"key":"e_1_3_2_194_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58504-z"},{"key":"e_1_3_2_195_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-021-00320-9"},{"key":"e_1_3_2_196_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-025-01186-x"},{"key":"e_1_3_2_197_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201810-1921OC"},{"key":"e_1_3_2_198_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012198"},{"key":"e_1_3_2_199_2","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adj7611"},{"key":"e_1_3_2_200_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-024-00917-w"},{"key":"e_1_3_2_201_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1012873"},{"key":"e_1_3_2_202_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06809-8"},{"key":"e_1_3_2_203_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60726-0"},{"key":"e_1_3_2_204_2","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11091427"},{"key":"e_1_3_2_205_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.06.013"},{"key":"e_1_3_2_206_2","doi-asserted-by":"publisher","unstructured":"Johnson S Martinez CI Jegede CB Gutierrez S Cortese M Martinez CJ Garg SJ Peinovich N Dora EG Tucker SN. 2022. SARS-CoV-2 oral tablet vaccination induces neutralizing mucosal IgA in a phase 1 open label trial. medRxiv. doi:10.1101\/2022.07.16.22277601:2022.07.16.22277601","DOI":"10.1101\/2022.07.16.22277601:2022.07.16.22277601"},{"key":"e_1_3_2_207_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abn6868"},{"key":"e_1_3_2_208_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2023.144371"},{"key":"e_1_3_2_209_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-88413-2"},{"key":"e_1_3_2_210_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113970"},{"key":"e_1_3_2_211_2","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202300889"},{"key":"e_1_3_2_212_2","doi-asserted-by":"publisher","DOI":"10.1093\/biomethods\/bpad017"},{"key":"e_1_3_2_213_2","doi-asserted-by":"publisher","DOI":"10.3390\/life12070975"},{"key":"e_1_3_2_214_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0708684105"},{"key":"e_1_3_2_215_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2024.05.041"},{"key":"e_1_3_2_216_2","first-page":"729","article-title":"Advantages of Intranasal Vaccination and Considerations on Device Selection","volume":"71","author":"Birkhoff M","year":"2009","unstructured":"Birkhoff M, Leitz M, Marx D. 2009. Advantages of Intranasal Vaccination and Considerations on Device Selection. Indian J Pharm Sci 71:729\u2013731.","journal-title":"Indian J Pharm Sci"},{"key":"e_1_3_2_217_2","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2045853"},{"key":"e_1_3_2_218_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.2.680"},{"key":"e_1_3_2_219_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.860399"},{"key":"e_1_3_2_220_2","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01295-23"},{"key":"e_1_3_2_221_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2019.05.003"},{"key":"e_1_3_2_222_2","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11071232"},{"key":"e_1_3_2_223_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri1777"},{"key":"e_1_3_2_224_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0119408"},{"key":"e_1_3_2_225_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030595"},{"key":"e_1_3_2_226_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2023.0160"},{"key":"e_1_3_2_227_2","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2011.0931"},{"key":"e_1_3_2_228_2","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13030261"},{"key":"e_1_3_2_229_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2014.05.060"},{"key":"e_1_3_2_230_2","unstructured":"CDC. 2023. Vaccine administration. Available from: https:\/\/www.cdc.gov\/vaccines\/hcp\/acip-recs\/general-recs\/administration.html"},{"key":"e_1_3_2_231_2","unstructured":"Care AGDoHaA. 2022. Information for adults with a needle phobia. Care DoHaA"},{"key":"e_1_3_2_232_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291721002609"},{"key":"e_1_3_2_233_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.112721"},{"key":"e_1_3_2_234_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-023-02942-3"},{"key":"e_1_3_2_235_2","unstructured":"ClinicalTrials.gov. 2024. Safety and immunogenicity trial of MPV\/S-2P SARS-CoV-2 vaccine in adults. Available from: https:\/\/www.clinicaltrials.gov\/study\/NCT06441968?term=NCT06441968&rank=1"},{"key":"e_1_3_2_236_2","unstructured":"ClinicalTrials.gov. 2024. Phase I safety study of B\/HPIV3\/S-6P vaccine via nasal spray in adults. Available from: https:\/\/www.clinicaltrials.gov\/study\/NCT06026514?cond=Covid19&intr=nasal%20vaccine&rank=2"},{"key":"e_1_3_2_237_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-025-01096-y"},{"key":"e_1_3_2_238_2","unstructured":"ClinicalTrials.gov. 2025. A phase 1 first-in-human study of the investigational COVID-19 vaccine SC-Ad6-1 in healthy volunteers. Available from: https:\/\/www.clinicaltrials.gov\/study\/NCT04839042"},{"key":"e_1_3_2_239_2","unstructured":"ClinicalTrials.gov. 2025. The safety and antibody response of the nasal COV2 vaccine against the SARS-CoV-2 virus (COV2NOSE). Available from: https:\/\/clinicaltrials.gov\/study\/NCT06851611"},{"key":"e_1_3_2_240_2","unstructured":"ClinicalTrials.gov. 2021. A phase I study to determine safety and immunogenicity of the candidate COVID-19 vaccine AZD1222 delivered by aerosol in healthy adult volunteers. Available from: https:\/\/www.clinicaltrials.gov\/study\/NCT05007275"},{"key":"e_1_3_2_241_2","unstructured":"ClinicalTrials.gov. 2025. Randomized controlled multicenter phase I\/II study comparing the safety and immunogenicity of a booster dose of an intranasal COVID-19 vaccine expressing SARS-CoV-2 N\/S recombinant proteins with a booster dose of COVID-19 mRNA vaccine in healthy adults (MUCOBOOST). Available from: https:\/\/clinicaltrials.gov\/study\/NCT06821126"},{"key":"e_1_3_2_242_2","unstructured":"Lovaltech. 2023. Versatile mucosal vaccines"},{"key":"e_1_3_2_243_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-017-0605-3"},{"key":"e_1_3_2_244_2","unstructured":"EMA. 2013. Product-information\/fluenz-tetra-epar-product-information_en"},{"key":"e_1_3_2_245_2","unstructured":"EMA. 2016. Pandemic-influenza-vaccine-h5n1-astrazeneca-epar-product-information"},{"key":"e_1_3_2_246_2","unstructured":"ClinicalTrials.gov. 2023. Safety and immunogenicity of CodaVax-RSV in seropositive and seronegative children. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04919109"},{"key":"e_1_3_2_247_2","unstructured":"Sanofi. 2023. Innovation to drive sustainable growth in vaccines Part 1 on Sanofi. Available from: https:\/\/www.sanofi.com\/assets\/dotcom\/content-app\/events\/investor-presentation\/2023\/vaccines-investor-event\/presentation-vaccines-event-2023.pdf"},{"key":"e_1_3_2_248_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac253"},{"key":"e_1_3_2_249_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz603"},{"key":"e_1_3_2_250_2","unstructured":"ClinicalTrials.gov. 2024. Evaluating the infectivity safety and immunogenicity of respiratory syncytial virus vaccines RSV 6120\/\u2206NS1 and RSV 6120\/F1\/G2\/\u2206NS1 in RSV-seropositive children and RSV-seronegative infants and children. https:\/\/www.clinicaltrials.gov\/study\/NCT03596801?limit=10&cond=Respiratory%20virus&intr=nasal&aggFilters=status:rec%20act&page=2&rank=17."},{"key":"e_1_3_2_251_2","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8040672"},{"key":"e_1_3_2_252_2","unstructured":"ClinicalTrials.gov. 2023. A study of BLB-201 RSV vaccine in infants and children. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05655182"},{"key":"e_1_3_2_253_2","unstructured":"Biotechnology BL. 2024. Blue lake biotechnology reports additional promising clinical data from ongoing pediatric clinical study of intranasal RSV vaccine BLB201"},{"key":"e_1_3_2_254_2","unstructured":"ClinicalTrials.gov. 2024. Study of the infectivity safety and immunogenicity of two recombinant live-attenuated B\/HPIV3 vectored vaccines expressing the fusion glycoprotein of HMPV delivered by nasal spray to HPIV3- seropositive children 24 to <60 months of age. Available from: https:\/\/www.clinicaltrials.gov\/study\/NCT06546423?limit=10&aggFilters=status:rec%20act&cond=human%20metapneumovirus%20&rank=1"},{"key":"e_1_3_2_255_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-025-01155-4"},{"key":"e_1_3_2_256_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59353-6"},{"key":"e_1_3_2_257_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.858904"},{"key":"e_1_3_2_258_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02025-6"},{"key":"e_1_3_2_259_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1005321"},{"key":"e_1_3_2_260_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105615"},{"key":"e_1_3_2_261_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.781280"},{"key":"e_1_3_2_262_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.abo2523"},{"key":"e_1_3_2_263_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2018.03.007"},{"key":"e_1_3_2_264_2","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12101121"},{"key":"e_1_3_2_265_2","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms12112294"},{"key":"e_1_3_2_266_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013972"},{"key":"e_1_3_2_267_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-023-02044-9"},{"key":"e_1_3_2_268_2","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12121354"},{"key":"e_1_3_2_269_2","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70146"},{"key":"e_1_3_2_270_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-024-00987-w"},{"key":"e_1_3_2_271_2","doi-asserted-by":"publisher","DOI":"10.3390\/v15091846"},{"key":"e_1_3_2_272_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47784-6"},{"key":"e_1_3_2_273_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abo2847"},{"key":"e_1_3_2_274_2","unstructured":"ClinicalTrials.gov. 2024. A live recombinant newcastle disease virus-vectored COVID-19 vaccine phase 1 study. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05181709?term=Recombinant%20NDV%20Vectored%20Vaccine%20for%20SARS-CoV-2&aggFilters=status:act&rank=2"},{"key":"e_1_3_2_275_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adu7646"},{"key":"e_1_3_2_276_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aac5745"},{"key":"e_1_3_2_277_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.920256"},{"key":"e_1_3_2_278_2","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1779517"},{"key":"e_1_3_2_279_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.04.089"},{"key":"e_1_3_2_280_2","doi-asserted-by":"publisher","DOI":"10.1093\/cei\/uxad003"},{"key":"e_1_3_2_281_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2019.02.003"},{"key":"e_1_3_2_282_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-008748"},{"key":"e_1_3_2_283_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2015.03.032"},{"key":"e_1_3_2_284_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.02.056"},{"key":"e_1_3_2_285_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2102775118"},{"key":"e_1_3_2_286_2","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.12461.1"},{"key":"e_1_3_2_287_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.03192-15"},{"key":"e_1_3_2_288_2","doi-asserted-by":"publisher","DOI":"10.1093\/ve\/vev005"},{"key":"e_1_3_2_289_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1155761"},{"key":"e_1_3_2_290_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107586"},{"key":"e_1_3_2_291_2","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13395"},{"key":"e_1_3_2_292_2","unstructured":"Australian Government. 2023. Australian public assessment report for flucelvax quad. https:\/\/www.tga.gov.au\/sites\/default\/files\/2023-11\/auspar-flucelvax-quad-231101.pdf."},{"key":"e_1_3_2_293_2","unstructured":"Astrazeneca. 2013. Fluenz Tetra four-strain nasal spray vaccine receives positive opinion in EU from CHMP for the prevention of seasonal influenza in children. Available from: https:\/\/www.astrazeneca.com\/media-centre\/press-releases\/2013\/fluenz-tetra-nasal-spray-vaccine-eu-chmp-positive-opinion-seasonal-influenza-prevention-children-20092013.html"},{"key":"e_1_3_2_294_2","unstructured":"Government I. 2012. Summary of product charateristics organization CDSC. https:\/\/cdsco.gov.in\/opencms\/resources\/UploadCDSCOWeb\/2018\/UploadSmPC\/5serum.pdf."},{"key":"e_1_3_2_295_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy1003"},{"key":"e_1_3_2_296_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(16)30200-5"},{"key":"e_1_3_2_297_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(16)30201-7"},{"key":"e_1_3_2_298_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu616"},{"key":"e_1_3_2_299_2","unstructured":"ClinicalTrials.gov. 2024. Safety and immunogenicity of CodaVax-RSV in seropositive and seronegative children. Available from: https:\/\/www.clinicaltrials.gov\/study\/NCT04919109?limit=10&cond=Respiratory%20virus&intr=nasal&rank=6"},{"key":"e_1_3_2_300_2","unstructured":"ClinicalTrials.gov. 2024. Evaluating the infectivity safety and immunogenicity of a recombinant live-attenuated respiratory syncytial virus vaccine LID\/\u0394M2-2\/1030s in RSV-seronegative infants and children 6 to 24 months of age. Available from: https:\/\/www.clinicaltrials.gov\/study\/NCT04520659?limit=10&cond=Respiratory%20virus&intr=nasal&aggFilters=status:rec%20act&page=2&rank=20%20"},{"key":"e_1_3_2_301_2","unstructured":"ClinicalTrials.gov. 2023. Evaluating the safety and immune response to a single dose of a respiratory syncytial virus (RSV) vaccine in infants and children. Available from: https:\/\/www.clinicaltrials.gov\/study\/NCT01893554?limit=10&cond=Respiratory%20virus&intr=nasal&aggFilters=status:rec%20act&rank=3"},{"key":"e_1_3_2_302_2","unstructured":"ClinicalTrials.gov. 2024. Study on a live-attenuated respiratory syncytial virus vaccine for assessment of safety transmissibility and genetic stability of the vaccine virus among close contacts in infants and toddlers 6 to < 24 months of age in Puerto Rico (USA). Available from: https:\/\/clinicaltrials.gov\/study\/NCT05687279?term=NCT05687279&rank=1"},{"key":"e_1_3_2_303_2","unstructured":"ClinicalTrials.gov. 2025. Efficacy immunogenicity and safety study of a respiratory syncytial virus vaccine in infants and toddlers (PEARL). Available from: https:\/\/clinicaltrials.gov\/study\/NCT06252285?term=NCT06252285&rank=1"},{"key":"e_1_3_2_304_2","unstructured":"ClinicalTrials.gov. 2025. Co-administration study of an investigational live-attenuated respiratory syncytial virus vaccine in infants and toddlers (CORAL). Available from: https:\/\/clinicaltrials.gov\/study\/NCT06397768?term=NCT06397768&rank=1"},{"key":"e_1_3_2_305_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2009.05.016"},{"key":"e_1_3_2_306_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.idnow.2022.09.011"},{"key":"e_1_3_2_307_2","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-025-00818-6"},{"key":"e_1_3_2_308_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27063-4"},{"key":"e_1_3_2_309_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-024-00857-5"},{"key":"e_1_3_2_310_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50087-5"},{"key":"e_1_3_2_311_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-024-00912-1"}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/jvi.00146-26","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/jvi.00146-26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T13:07:56Z","timestamp":1780492076000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/jvi.00146-26"}},"subtitle":[],"editor":[{"given":"Herman W.","family":"Favoreel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":310,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,19]]}},"alternative-id":["10.1128\/jvi.00146-26"],"URL":"https:\/\/doi.org\/10.1128\/jvi.00146-26","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"2026-04-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00146-26"}}